Global Nasal Swab Test Market to be worth around USD 150.7 Million by End of 2026

17-Dec-2021 | Facts and Factors

“Nasal Swab Test Market By Product Type (Non-woven, Foam-tipped Swabs, and Others), By Diagnostics Type (Molecular Diagnostics, CRISPR & Biosensors, and Others), By Mode (Point-of-Care, and Non-Point-of-Care), and By End-User (Laboratories & Diagnostics Centers, Hospitals & Clinics, and Others): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2021–2026” states that the global demand for the nasal swab test market in 2020 was approximately USD 108.7 Million. The market is expected to grow at a CAGR of 3.4% and is likely to reach around USD 150.7 Million by 2026.

The Coronavirus refers to a collection of encompassed, single abandoned RNA infections, which contaminate people, numerous warm-blooded creatures, chimpanzees, and avian species. Mostly, it causes respiratory and gastrointestinal contaminations and takes about 3 to 14 days for a person to show symptoms after directness to the infection. Few symptoms of COVID-19 consist of fatigue, dry cough, fever, and body ache. Individuals with conditions like cancer, diabetes, hypertension, old age, and others are at a high risk of getting severe COVID-19 infection. As a result, it is important to test for COVID-19 disease, so the COVID-19 spread can be in control.

The rising number of novel coronavirus cases is a key factor driving the global nasal swab test market growth. In addition, the growth of the global nasal swab test market is driven by the growing prevalence of infectious diseases, and the increasing need for surgical masks, as well as other hygiene products. Other factors that are expected to propel the market growth are the rising number of research and development activities for the improvement of the efficiency of nasal swab tests. Besides, the escalating government funding supports the research and development activities, which is also likely to boost the global nasal swab tests market development in the future. 

However, the global nasal swab test market growth might get hampered due to the growing product recalls.

The global COVID-19 nasal swab test market can be classified into North America, Latin America, Asia-Pacific, Europe, and the Middle East, and Africa. North America is projected to have a leading place in the global nasal swab test market in the upcoming years. This is due to the increasing demand for diagnostic procedures, the expanding number of product launches, and the escalating occurrence of infectious diseases. Other factors that might help the regional market to expand include the escalating demand for medical swabs and the existence of advanced research centers.

The Asia-Pacific nasal swab test market will observe beneficial growth opportunities during the forecast period owing to the growing cases of coronavirus as a result of the presence of highly populated countries like India, China, Japan, and others. In addition, the rising number of coronavirus testing facilities in the emerging nations will probably help this region to experience significant growth in the near future.

Roche Holding AG, Abbott Laboratories, Becton Dickinson & Company, BioMerieux SA, 3M Corporation, Lucira Health, Siemens Healthineers AG, Mesa Biotech Inc., QIAGEN N.V., LumiraDx Ltd., Cepheid, Fluidigm Corporation, GenMark Diagnostics Inc., Quidel Corporation, Sherlock Biosciences, OraSure Technologies Inc, and PrivaPath Diagnostics Limited, among others are several market players operating in the global nasal swab test market. In addition, major market players are concentrating on many marketing strategies like collaborations, partnerships, and others, leading the global nasal swab test market development.

Browse the full “Nasal Swab Test Market By Product Type (Non-woven, Foam-tipped Swabs, and Others), By Diagnostics Type (Molecular Diagnostics, CRISPR & Biosensors, and Others), By Mode (Point-of-Care, and Non-Point-of-Care), and By End-User (Laboratories & Diagnostics Centers, Hospitals & Clinics, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2026” report at https://www.fnfresearch.com/nasal-swab-test-market

This report segments the global nasal swab test market as follows:

Global Nasal Swab Test Market: By Product Type

• Non-woven
• Foam-tipped Swabs
• Others

Global Nasal Swab Test Market: By Diagnostics Type

• Molecular Diagnostics
• CRISPR & Biosensors
• Others

Global Nasal Swab Test Market: By Mode

• Point-of-Care
• Non-Point-of-Care

Global Nasal Swab Test Market: By End-User

• Laboratories &Diagnostics Centers
• Hospitals & Clinics
• Others

Global Nasal Swab Test Market: Regional Segmentation Analysis

• North America
  • The U.S.
  • Canada

• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]

Web: https://www.fnfresearch.com